JDRF T1D Fund — 2017 Investments

3 investments dated 2017 · listed companies and verified rows first · show all

Provention Bioproventionbio.com 𝕏Apr 2017acquired by Sanofi

Sanofi is a pharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally.

BiotechHealthtechMedical DevicesLebanon, FR

Ashleigh Palmer(Executive Officer, Director)Francisco Leon, M.D.(Director)

BoardAnthony DiGiandomenico(Director)Cameron Gray(Director)

Semma Therapeuticssemma-tx.comNov 2017acquired by Vertex Pharmaceuticals · Sep 2019 · $950M

Cambridge, MA biotech developing stem cell-derived islet therapy plus an immune-protective device for type 1 diabetes; acquired by Vertex for $950M.

BiotechCambridge, US

Robert Millman(Executive Officer, Director)

Board Todd Foley(Executive Officer, Director)inMitch Finer(Director)Stephen Knight(Director)inJim Scopa(Director)William Sahlman(Director)

Co-investorsARCH Venture Partners F-Prime Capital ORI Capital Slater Technology Fund 6 Dimensions Capital Cowen Healthcare Investments +4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Diasome Pharmaceuticals

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.